Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-19
2006-09-19
Richter, Johann (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S317000, C514S319000, C514S520000, C514S521000, C549S474000, C546S251000, C544S183000, C544S239000, C548S243000, C558S409000
Reexamination Certificate
active
07109214
ABSTRACT:
The present invention relates to substituted cyclopentene compounds of the general formula I, to a process for the production thereof, to pharmaceutical preparations containing these compounds and to the use thereof for the production of pharmaceutical preparations.
REFERENCES:
patent: 5698584 (1997-12-01), Black et al.
patent: 5700816 (1997-12-01), Isakson et al.
patent: 6057319 (2000-05-01), Black et al.
patent: 6222048 (2001-04-01), Black et al.
patent: WO 95/18799 (1995-07-01), None
patent: WO 97/28121 (1997-08-01), None
patent: WO 98/56779 (1998-12-01), None
patent: WO 01/56382 (2001-08-01), None
patent: WO 2004/002420 (2004-01-01), None
“Efficient Syntheses of 2-(3′,5′-Difluorophenyl)-3-(4′-methylsulfonylphenyl)-cyclopent-2-enome, a Potent COX-2 Inhibitor”, Dalian Zhao, et al., Tetrahedron 55 (1999) 6001-6018.
“Weighing and Measuring”, Metrology and Calculation, pp. 76-91.
“A Potent and Selective Cgrp2Agonist, [Cys(Et)2,7]Hcgprα: Comparison In Prototypical Cgrp2In Vitro Bioassays1” Yvan Dumont, et al., Can. J. Physiol. Pharmacol. 75: 671-676 (1997).
“Efficient Synthesis of 2-(3′,5′-Difluorophenyl)-3-(4′-Methylsulfonylphenyl)-Cyclopent-2-Enone, A Potent Cox-2 Inhibitor”, Dalian Zhao, et al., Tetrahedron 55 (1999) 6001-6018.
“2,3-Diarylcyclopentenones as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors”, W. Cameron Black, et al., J. Med. Chem. 1999, 42, 1274-1281.
“A Novel High Throughput Chemiluminescent Assay for the Measurement of Cellular Cyclic Adenosine Monophosphate Levels”, Anthony C. Chiulli, et al., Journal of Biomolecular Screening, vol. 5, No. 4, 2000., 239-247.
“Organikum”, Heinz G. O. Becker, et al., ISBN 3-335-00343-8, 1993, 422-424.
“Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells”, F. Van Valem, et al., Neuroscience Letters, 199 (1990) 195-198.
Bahrenberg Gregor
Gillen Clemens
Haurand Michael
Schiene Klaus
Schneider Johannes
Grunenthal GmbH
Nwaonicha Chukwuma
Perman & Green, LLP.
Richter Johann
LandOfFree
Substituted cyclopentene compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclopentene compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclopentene compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3574187